NAVCO Pharmaceuticals Inc. — SEDAR+ Filings
Open SEDAR+
All
Annual Reports
7
Quarterly Reports
21
MD&A
28
News Releases
17
Material Changes
6
Prospectuses
2
Governance
12
Certifications
61
Other
59
| Document | Type | Filing Date | Period | Status |
|---|---|---|---|---|
| MD&A | 2026-01-29 | -- | ||
| MD&A | 2025-08-29 | -- | ||
| MD&A | 2025-05-29 | -- | ||
| MD&A | 2025-03-03 | -- | ||
| MD&A | 2025-02-10 | -- | ||
| MD&A | 2025-01-28 | -- | ||
| MD&A | 2024-08-29 | -- | ||
| MD&A | 2024-05-30 | -- | ||
| MD&A | 2024-02-27 | -- | ||
| MD&A | 2023-08-29 | -- | ||
| MD&A | 2023-05-30 | -- | ||
| MD&A | 2023-02-27 | -- | ||
| MD&A | 2022-11-29 | -- | ||
| MD&A | 2022-10-25 | -- | ||
| MD&A | 2022-05-30 | -- | ||
| MD&A | 2022-03-01 | -- | ||
| MD&A | 2021-11-26 | -- | ||
| MD&A | 2021-10-05 | -- | ||
| MD&A | 2021-05-31 | -- | ||
| MD&A | 2020-11-18 | -- | ||
| MD&A | 2020-10-27 | -- | ||
| MD&A | 2020-05-28 | -- | ||
| MD&A | 2020-02-19 | -- | ||
| MD&A | 2019-11-14 | -- | ||
| MD&A | 2019-10-17 | -- | ||
| MD&A | 2019-05-30 | -- | ||
| MD&A | 2019-02-28 | -- | ||
| MD&A | 2018-11-21 | -- |